Kevin P. Anderson

Person

Carlsbad, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Modulation of telomere length by oligonucleotides having a G-core s...
- Patent number 7,067,497
- Issue date Jun 27, 2006
- ISIS Pharmaceuticals, Inc.
- Ronnie C. Hanecak
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treatment of hepatitis C virus-associa...
- Patent number 6,995,146
- Issue date Feb 7, 2006
- ISIS Pharmaceuticals, Inc.
- Kevin P. Anderson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treatment of hepatitis C virus-associa...
- Patent number 6,608,191
- Issue date Aug 19, 2003
- ISIS Pharmaceuticals, Inc.
- Kevin P. Anderson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treatment of Hepatitis C virus associa...
- Patent number 6,433,159
- Issue date Aug 13, 2002
- ISIS Pharmaceuticals, Inc.
- Kevin P. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treatment of Hepatitis C virus-associa...
- Patent number 6,423,489
- Issue date Jul 23, 2002
- ISIS Pharmaceuticals, Inc.
- Kevin P. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treatment of Hepatitis C virus-associa...
- Patent number 6,391,542
- Issue date May 21, 2002
- ISIS Pharmaceuticals, Inc.
- Kevin P. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treatment of hepatitis C virus-associa...
- Patent number 6,284,458
- Issue date Sep 4, 2001
- ISIS Pharmaceuticals, Inc.
- Kevin P. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treatment of hepatitis C virus-associa...
- Patent number 6,174,868
- Issue date Jan 16, 2001
- ISIS Pharmaceuticals, Inc.
- Kevin P. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition and method for treatment of CMV infections
- Patent number 6,153,595
- Issue date Nov 28, 2000
- ISIS Pharmaceuticals Inc.
- Kenneth G. Draper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense inhibition of hepatitis B virus replication
- Patent number 5,985,662
- Issue date Nov 16, 1999
- ISIS Pharmaceuticals Inc.
- Kevin P. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligonucleotides having a conserved G4 core sequence
- Patent number 5,952,490
- Issue date Sep 14, 1999
- ISIS Pharmaceuticals, Inc.
- Ronnie C. Hanecak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2
- Patent number 5,789,573
- Issue date Aug 4, 1998
- ISIS Pharmaceuticals, Inc.
- Brenda Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for synthetic unrandomization of oligomer fragments
- Patent number 5,698,391
- Issue date Dec 16, 1997
- ISIS Pharmaceuticals, Inc.
- Phillip Dan Cook
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Synthetic unrandomization of oligomer fragments
- Patent number 5,672,472
- Issue date Sep 30, 1997
- ISIS Pharmaceuticals, Inc.
- David J. Ecker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides for modulating the effects of cytomegalovirus infe...
- Patent number 5,591,720
- Issue date Jan 7, 1997
- ISIS Pharmaceuticals, Inc.
- Kevin P. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligonucleotide therapies for modulating the effects of herpes viruses
- Patent number 5,514,577
- Issue date May 7, 1996
- ISIS Pharmaceuticals, Inc.
- Kenneth G. Draper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligonucleotides for modulating the effects of cytomegalovirus infe...
- Patent number 5,442,049
- Issue date Aug 15, 1995
- ISIS Pharmaceuticals, Inc.
- Kevin Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Antiviral Oligonucleotides Having a Conserved G4 Core Sequence
- Publication number 20110124715
- Publication date May 26, 2011
- Ronnie C. Hanecak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antiviral oligonucleotides having a conserved G4 core sequence
- Publication number 20070015723
- Publication date Jan 18, 2007
- ISIS Pharmaceuticals, Inc.
- Ronnie C. Hanecak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antisense modulation of interleukin 12 P35 subunit expression
- Publication number 20050261228
- Publication date Nov 24, 2005
- C. Frank Bennett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and mehtods for treatment of Hepatitis C virus-associa...
- Publication number 20040049021
- Publication date Mar 11, 2004
- Kevin P. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for treatment of Hepatitis C virus-associa...
- Publication number 20040033978
- Publication date Feb 19, 2004
- Kevin P. Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compositions and methods for treatment of hepatitis C virus-associa...
- Publication number 20030171313
- Publication date Sep 11, 2003
- Kevin P. Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulation of telomere length by oligonucleotides having a G-core s...
- Publication number 20030096776
- Publication date May 22, 2003
- ISIS Pharmaceuticals, Inc.
- Ronnie C. Hanecak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for antisense inhibition of protein transl...
- Publication number 20020052331
- Publication date May 2, 2002
- Brenda Baker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Kevin P. Anderson

Person

Patents Grantslast 30 patents

Modulation of telomere length by oligonucleotides having a G-core s...

Compositions and methods for treatment of hepatitis C virus-associa...

Compositions and methods for treatment of hepatitis C virus-associa...

Compositions and methods for treatment of Hepatitis C virus associa...

Compositions and methods for treatment of Hepatitis C virus-associa...

Compositions and methods for treatment of Hepatitis C virus-associa...

Compositions and methods for treatment of hepatitis C virus-associa...

Compositions and methods for treatment of hepatitis C virus-associa...

Composition and method for treatment of CMV infections

Antisense inhibition of hepatitis B virus replication

Oligonucleotides having a conserved G4 core sequence

Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2

Methods for synthetic unrandomization of oligomer fragments

Synthetic unrandomization of oligomer fragments

Oligonucleotides for modulating the effects of cytomegalovirus infe...

Oligonucleotide therapies for modulating the effects of herpes viruses

Oligonucleotides for modulating the effects of cytomegalovirus infe...

Patents Applicationslast 30 patents

Antiviral Oligonucleotides Having a Conserved G4 Core Sequence

Antiviral oligonucleotides having a conserved G4 core sequence

Antisense modulation of interleukin 12 P35 subunit expression

Compositions and mehtods for treatment of Hepatitis C virus-associa...

Compositions and methods for treatment of Hepatitis C virus-associa...

Compositions and methods for treatment of hepatitis C virus-associa...

Modulation of telomere length by oligonucleotides having a G-core s...

Compositions and methods for antisense inhibition of protein transl...